AROMESINE
Exemestane 25mg
Indication:
Is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy. Also for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Presentation:
Each carton contains of 2 x 25 tablets.